125 related articles for article (PubMed ID: 21612986)
1. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
Smoljanovic T; Bojanic I
Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
[No Abstract] [Full Text] [Related]
2. Another complication associated with rhBMP-2?
Kang JD
Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
[No Abstract] [Full Text] [Related]
3. Science please.
Zdeblick TA
Spine J; 2011 Jul; 11(7):686; author reply 687-90. PubMed ID: 21767996
[No Abstract] [Full Text] [Related]
4. Commentary: Retrograde ejaculation and the use of rhBMP-2 for anterior lumbar interbody fusion: what does the evidence say to surgeons and to patients?
Mroz TE; Abdullah KG; Benzel EC
Spine J; 2012 Oct; 12(10):891-3. PubMed ID: 23199820
[No Abstract] [Full Text] [Related]
5. Yet another reason for improving approval and surveillance processes for health technologies.
Kovacs FM; Olabe J; Urrútia G; Zamora J; Bagó J; Alvarez-Galovich L; Abraira V;
Spine J; 2011 Aug; 11(8):800-1; author reply 801. PubMed ID: 21778121
[No Abstract] [Full Text] [Related]
6. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
[TBL] [Abstract][Full Text] [Related]
7. Acknowledging the elephant in the room: conflict of interest in industry-sponsored clinical research.
Hart RA
Spine J; 2011 Aug; 11(8):703-4. PubMed ID: 21925414
[No Abstract] [Full Text] [Related]
8. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
Lehman RA; Kang DG
Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
[No Abstract] [Full Text] [Related]
9. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
[TBL] [Abstract][Full Text] [Related]
10. Vertebral body osteolysis after minimal-access transforaminal interbody fusion.
Lehman RA
Spine J; 2011 Jun; 11(6):581-2. PubMed ID: 21729806
[No Abstract] [Full Text] [Related]
11. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
14. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
15. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
[TBL] [Abstract][Full Text] [Related]
17. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Recombinant human bone morphogenetic protein-2.
Shaffrey CI; Smith JS
J Neurosurg Spine; 2013 Feb; 18(2):109-10; discussion 110-1. PubMed ID: 23198758
[No Abstract] [Full Text] [Related]
19. RE: complications attributable to the use of rhBMP-2 inside the femoral ring allograft during anterior lumbar interbody fusion.
Smoljanovic T; Pecina M
Spine J; 2008; 8(2):413-4; author reply 414. PubMed ID: 18178134
[No Abstract] [Full Text] [Related]
20. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
